GAINESVILLE— October 13, 2020— Rescue Hearing Inc., a team of visionary, internationally recognized physicians, scientists, and bioengineers focused on developing new gene therapies to eliminate hearing loss, announced the addition of Business Advisor Andrew Koopman.
“Andrew is a native New Yorker and longtime participant in the NYC life science entrepreneurial ecosystem who has developed many relationships over the years,” said RHI CEO Jim Ayala. Over the course of more than a decade at NYU, Andrew had worked alongside many life science startups. Further, he brings with him investment banking and “big pharma” experience. He will be helping RHI to identify and approach prospective investors Andrew is a very good fit with RHI’s culture of bringing technology from ‘Bench to Clinic.’”
Andrew Koopman joins RHI with more than 30 years in the Biotechnology and Biomedical industries. He is currently a business development consultant and strategic advisor, working with universities, investors, biotechnology/biomedical startups, and incubators. He is also a member of the Board of Directors for PainQx, Inc., an officer in Applied Glycan Technologies, Inc., and an NIH SBIR mentor. Prior to consulting, Mr. Koopman was CEO and President of Zero Gravity Life Sciences where he was responsible for the development and execution of the strategic business plan, intellectual property and grant strategies, and management of the scientific team. From 2006 to 2016, he was Director of New Ventures at New York University where he launched and built startup companies based upon NYU’s life science technologies. Prior to that, he served as a Managing Director at Beroff Associates, a boutique merchant investment bank, after a decade in the pharmaceutical industry. Throughout his career, Koopman has gained extensive industry knowledge and experience in Life Sciences, Pharmaceuticals, Product Development, Business Development, Entrepreneurship, Corporate Strategy, Research and Development, Medical Devices, Licensing, and more.
“I am excited to join this strongly committed team of world-class scientists and industry veterans in their mission to address the great need for durable hearing loss solutions,” said Andrew Koopman.
Mr. Koopman’s advisory activities will include investor relations, technology licensing, non-dilutive funding, and corporate strategy.
About Rescue Hearing Inc
Rescue Hearing Inc. combines the top physicians and researchers with cutting-edge technologies in gene therapy and diagnostics to develop a diversified asset portfolio for patients with hearing loss.